CANOQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CANOQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cano Health's Total Assets for the quarter that ended in Mar. 2024 was $1,046 Mil.
During the past 12 months, Cano Health's average Total Assets Growth Rate was -54.40% per year. During the past 3 years, the average Total Assets Growth Rate was 16.60% per year.
During the past 5 years, Cano Health's highest 3-Year average Total Assets Growth Rate was 16.60%. The lowest was 16.60%. And the median was 16.60%.
Total Assets is connected with ROA %. Cano Health's annualized ROA % for the quarter that ended in Mar. 2024 was -161.50%. Total Assets is also linked to Revenue through Asset Turnover. Cano Health's Asset Turnover for the quarter that ended in Mar. 2024 was 0.66.
The historical data trend for Cano Health's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cano Health Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Total Assets | - | 614.19 | 2,143.54 | 1,928.93 | 1,013.74 |
Cano Health Quarterly Data | |||||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Total Assets | Get a 7-Day Free Trial | 1,944.38 | 1,707.32 | 1,211.93 | 1,013.74 | 1,045.55 |
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Cano Health's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
Total Assets | = | Total Equity (A: Dec. 2023 ) | + | Total Liabilities (A: Dec. 2023 ) |
= | -535.001 | + | 1548.74 | |
= | 1,014 |
Cano Health's Total Assets for the quarter that ended in Mar. 2024 is calculated as
Total Assets | = | Total Equity (Q: Mar. 2024 ) | + | Total Liabilities (Q: Mar. 2024 ) |
= | -1009.206 | + | 2054.752 | |
= | 1,046 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cano Health (OTCPK:CANOQ) Total Assets Explanation
Total Assets is connected with ROA %.
Cano Health's annualized ROA % for the quarter that ended in Mar. 2024 is
ROA % | = | Net Income (Q: Mar. 2024 ) | / | ( (Total Assets (Q: Dec. 2023 ) | + | Total Assets (Q: Mar. 2024 )) | / count ) |
= | -1662.824 | / | ( (1013.739 | + | 1045.546) | / 2 ) | |
= | -1662.824 | / | 1029.6425 | ||||
= | -161.50 % |
Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Cano Health's Asset Turnover for the quarter that ended in Mar. 2024 is
Asset Turnover | ||||||
= | Revenue (Q: Mar. 2024 ) | / | ( (Total Assets (Q: Dec. 2023 ) | + | Total Assets (Q: Mar. 2024 )) | / count ) |
= | 684.426 | / | ( (1013.739 | + | 1045.546) | / 2 ) |
= | 684.426 | / | 1029.6425 | |||
= | 0.66 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of Cano Health's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Elliot Cooperstone | director, 10 percent owner | C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Eladio Gil | officer: Interim CFO | 9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178 |
Robert Camerlinck | officer: Chief Operating Officer | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Richard Aguilar | officer: Chief Clinical Officer | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Mark D. Kent | officer: Interim CEO | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
David J Armstrong | officer: See Remarks | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Brian D Koppy | officer: Chief Financial Officer | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Lewis Gold | director | 1235 SPANISH RIVER ROAD, BOCA RATON FL 33432 |
Marlow Hernandez | director, officer: See Remarks | 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Solomon D Trujillo | director | 1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403 |
Alan Muney | director | 48 MONROE TURNPIKE, TRUMBULL CT 06611 |
Kim M Rivera | director | 601 HAWAII ST, EL SEGUNDO CA 90245 |
Itc Rumba, Llc | 10 percent owner | 444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022 |
Jacqueline Guichelaar | director | C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
Angel L Morales | director | C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178 |
From GuruFocus
By Business Wire Business Wire • 06-20-2023
By Business Wire • 07-17-2023
By PRNewswire • 11-20-2023
By PRNewswire PRNewswire • 05-31-2023
By PRNewswire PRNewswire • 06-08-2023
By Business Wire Business Wire • 05-25-2023
By PRNewswire • 06-22-2023
By PRNewswire • 12-18-2023
By PRNewswire • 11-14-2023
By PRNewswire PRNewswire • 06-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.